Avidity Biosciences
RNA
$39.64
Share price
-0.80%
Change (1 day)
217.63%
Change (1 year)
Categories
Market capitalization of Avidity Biosciences (RNA)
Market cap: $3.79 Billion
As of June 2024 Avidity Biosciences has a market cap of $3.79 Billion. This makes Avidity Biosciences the world's 3068th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Avidity Biosciences from 2020 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.79 B | 429.07% |
| 2023 | $0.71 B | -51.41% |
| 2022 | $1.47 B | 32.3% |
| 2021 | $1.11 B | 16.4% |
| 2020 | $0.95 B |
End of Day market cap according to different sources
On Jun 15th, 2024 the market cap of Avidity Biosciences was reported to be:
$3.79 Billion
$3.79 Billion
$3.79 Billion
$3.79 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $156.00 B | 4,015.00% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $82.88 B | 2,086.38% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $11.61 B | 206.28% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.74 B | -27.55% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.41 B | -89.16% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -99.98% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 188.35% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $1.77 B | -53.08% | 🇺🇸 USA |